Back
EyePoint Pharmaceuticals Stock Price Chart
Sponsored
EYPT
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
EYPT
EyePoint Pharmaceuticals
Last Price:
8.92
Seasonality Move:
-10.5%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EyePoint Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.74 | Buy |
20-day SMA: | 8.69 | Buy |
50-day SMA: | 8.9 | Buy |
200-day SMA: | 16.43 | Sell |
8-day EMA: | 8.82 | Buy |
20-day EMA: | 8.69 | Buy |
50-day EMA: | 9.08 | Buy |
200-day EMA: | 12.35 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 56.5 | Buy |
Chaikin Money Flow: | -434949 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.11 - 9.07) | Buy |
Bollinger Bands (100): | (7.53 - 12.27) | Sell |
EyePoint Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 9.18 while EYPT 8-day simple moving average is 8.74, which is a Buy signal.
- The stock price of EYPT is 9.18 while EyePoint Pharmaceuticals 20-day SMA is 8.69, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 8.90 while EYPT share price is 9.18, making it a Buy technically.
- EYPT stock price is 9.18 and EyePoint Pharmaceuticals 200-day simple moving average is 16.43, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
68
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $9.18. The Score for EYPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
491.3M
Price in USD:
9.18
Share Volume:
679.74K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Buy
68
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 9.18 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 9.18 while EYPT 8-day exponential moving average is 8.82, which is a Buy signal.
- The stock price of EYPT is 9.18 while EyePoint Pharmaceuticals 20-day EMA is 8.69, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.08 while EYPT share price is 9.18, making it a Buy technically.
- EYPT stock price is 9.18 and EyePoint Pharmaceuticals 200-day simple moving average is 12.35, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting EyePoint Pharmaceuticals is a Buy
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 56.5, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.11 - 9.07), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.53 - 12.27), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.